AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $691,000 | -51.3% | 45,665 | -75.8% | 0.00% | -50.0% |
| Q2 2022 | $1,418,000 | -15.3% | 189,026 | +2.7% | 0.00% | 0.0% |
| Q1 2022 | $1,675,000 | +83.5% | 184,014 | +41.4% | 0.00% | +100.0% |
| Q4 2021 | $913,000 | -21.6% | 130,110 | +27.4% | 0.00% | -50.0% |
| Q3 2021 | $1,164,000 | -10.8% | 102,126 | +25.2% | 0.00% | 0.0% |
| Q2 2021 | $1,305,000 | -14.5% | 81,539 | -4.5% | 0.00% | -33.3% |
| Q1 2021 | $1,526,000 | +18.3% | 85,379 | -10.6% | 0.00% | +50.0% |
| Q4 2020 | $1,290,000 | -30.5% | 95,494 | -39.5% | 0.00% | -50.0% |
| Q3 2020 | $1,856,000 | +26.6% | 157,730 | +58.8% | 0.00% | +33.3% |
| Q2 2020 | $1,466,000 | +26.7% | 99,303 | +15.6% | 0.00% | 0.0% |
| Q1 2020 | $1,157,000 | -62.4% | 85,887 | -33.0% | 0.00% | -50.0% |
| Q4 2019 | $3,080,000 | +6.6% | 128,256 | -14.6% | 0.01% | -14.3% |
| Q3 2019 | $2,890,000 | -4.8% | 150,243 | +45.9% | 0.01% | -12.5% |
| Q2 2019 | $3,036,000 | -33.3% | 102,978 | +7.9% | 0.01% | -38.5% |
| Q1 2019 | $4,550,000 | +44.6% | 95,456 | +9.9% | 0.01% | +30.0% |
| Q4 2018 | $3,147,000 | -38.9% | 86,836 | +3.5% | 0.01% | -33.3% |
| Q3 2018 | $5,151,000 | -2.6% | 83,880 | +7.2% | 0.02% | -6.2% |
| Q2 2018 | $5,288,000 | +26.4% | 78,265 | +1.4% | 0.02% | +23.1% |
| Q1 2018 | $4,182,000 | -18.1% | 77,176 | -9.7% | 0.01% | -18.8% |
| Q4 2017 | $5,104,000 | +24.0% | 85,458 | +0.7% | 0.02% | +14.3% |
| Q3 2017 | $4,117,000 | -6.0% | 84,837 | +2.0% | 0.01% | -12.5% |
| Q2 2017 | $4,382,000 | +10.3% | 83,182 | -5.0% | 0.02% | +6.7% |
| Q1 2017 | $3,973,000 | +12.0% | 87,601 | -6.4% | 0.02% | 0.0% |
| Q4 2016 | $3,548,000 | -1.1% | 93,551 | -1.4% | 0.02% | -6.2% |
| Q3 2016 | $3,587,000 | +80.7% | 94,857 | -15.9% | 0.02% | +77.8% |
| Q2 2016 | $1,985,000 | +28.7% | 112,788 | -11.1% | 0.01% | +12.5% |
| Q1 2016 | $1,542,000 | -33.8% | 126,808 | +32.6% | 0.01% | -33.3% |
| Q4 2015 | $2,329,000 | +45.4% | 95,638 | +5.9% | 0.01% | +33.3% |
| Q3 2015 | $1,602,000 | -64.5% | 90,283 | -64.7% | 0.01% | -25.0% |
| Q2 2015 | $4,516,000 | -15.8% | 255,912 | +49.5% | 0.01% | -58.6% |
| Q1 2015 | $5,364,000 | -74.3% | 171,169 | -65.2% | 0.03% | -75.0% |
| Q4 2014 | $20,911,000 | +416.7% | 492,162 | +151.7% | 0.12% | +222.2% |
| Q3 2014 | $4,047,000 | – | 195,567 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|